摘要
大多数骨肉瘤均有HER2及P糖蛋白(P gp)的表达。P gp介导的多药耐药性(MDR)是骨肉瘤化疗不敏感的重要原因,也是影响预后的重要因素,而致癌基因HER2的表达与否则提示肿瘤恶性程度高低及转移能力的强弱。作者拟对HER2及P gp的表达及其与骨肉瘤预后的关系作一综述。
HER2 and P-gp are expressed in most of the human osteosarcoma tissue. The multidrug resistance of osteosarcoma is mediated by P-gp. The insusceptibility of human osteosarcoma to chemotherapy and the poor prognosis is correlated with the expression of P-gp. The expression of the carcinogene HER2 is a prognostic risk factor of the malignancy and metastasis of osteosarcoma. The review will narrate the expression of the HER2 and P-gp in osteosarcoma and its prognostic significance.
出处
《医学研究生学报》
CAS
2005年第5期462-464,共3页
Journal of Medical Postgraduates